🔬 Did you know research from our collaborative CIBMTR program suggests a fully matched donor is no longer needed for blood stem cell transplants? Check out how this groundbreaking study will help offer life-saving #celltherapy to more patients 👉 youtu.be/-WzJVFQcibk

The EBMT Anthony Nolan CIBMTR # Bronwen Shaw describing how registries can guide clinical trials to speed up finding the best donor providing improved outcomes.

Interesting findings brilliantly presented by Karthik Nath at #EBMT24 .

Use of a young MUD is associated with superior disease control and higher DFS compared to older MSDs, and may be preferred when available, in patients aged ≥50-years receiving CNI-based GvHD prophylaxis.

A ​person’s ​race ​and ​health​ insurance ​may​ affect​ which ​treatments ​they​ receive​ for multiple myeloma. Learn more about this recent CIBMTR study: cibmtr.org/Files/Patient-…

Though #BMT can cure many diseases, it also can have serious long-term side effects such as #GVHD , lung conditions, hormone changes or cognitive difficulties. Special checkups are important. Read about more recommendations, here: cibmtr.org/Files/Patient-…

CMS is expanding Medicare coverage for allogeneic transplant for high risk MDS. Big win for patients. Appreciate ⁦CIBMTR⁩ for facilitating CED trial. Appreciate advocacy by ⁦ASTCT⁩ and ⁦NMDP⁩ to get this across the finish line. cms.gov/medicare-cover…

Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allo-HSCT: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
nature.com/articles/s4140…
Bone Marrow Transplantation The EBMT The EBMT_Trainee CIBMTR APBMT

Don't miss this recent important publication in Transplantation and Cellular Therapy Journal! International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update. astctjournal.org/article/S2666-…

CIBMTR's 2023 Annual Report is now available to view on our website. Thank you for helping us make 2023 another successful year!

cibmtr.org/Files/Administ…

Thank you to everyone who attended #Tandem24 . Safe travels and we look forward to seeing you next year in Honolulu, HI, for #Tandem25 ASTCT

Thank you for attending #Tandem24 !The combination of science and clinical care is essential for improving patient outcomes, and your dedication to this mission is truly commendable. Please join us next year in Hawaii for #Tandem25 . ASTCT CIBMTR

Proud of Sarah Hatley from HCA Healthcare Sarah Cannon Docs data team who was awarded best abstract award at CIBMTR data managers session at #Tandem24

The final #Tandem24 plenary session kicks off at 4:15 p.m.: “Selecting an Ideal HLA-Mismatched Donor: Old Art, New Science.” ASTCT

Late-Breaking Abstracts will be presented from 3:15-4:15 p.m. today #Tandem24 ASTCT

Live at #Tandem24 ! CIBMTR Collaborate: The Insider Scoop!

Make sure to attend “CIBMTR Collaborate: The Insider Scoop” from 1-3 p.m. this afternoon! #Tandem24

Oral abstract sessions begin at 10:30 a.m. ASTCT

Thank you #Tandem24 supporters! #appreciation 🥰🤩🙏🏼

Saturday’s ASTCT #Tandem24 plenary session starts at 8:30 a.m.: “The Future of Cellular and Gene Therapy.” Arrive early for the day’s welcome and awards session!

Enjoying a #Tandem24 evening with @cibmtr WTCL program (all ⭐️s), statisticians and Sci Directors and Joe, our 🛥️ Captain. Such a great way to celebrate our 1st WCTL Tandem!!!